Live Breaking News & Updates on Odette Cancer Centre Pharmacy

Stay updated with breaking news from Odette cancer centre pharmacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More


On Monday,
Tilray, Inc. (NASDAQ:TLRY) and
Aphria, Inc. (NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion. Benzinga spoke with
Irwin Simon, CEO of the new combined company.
Check out the video below:
Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.
Jazz Pharmaceuticals (NASDAQ:JAZZ) finalized its acquisition of
GW Pharmaceuticals plc. (NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion net of GW Pharma s cash.
Meanwhile,
Ascend Wellness Holdings (CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share. ....

New York , United States , Miami Beach , Prince William County , Green Market , Corey Mangold , Jared Polis , Stephen Herron , Jeff Graham , Irwin Simon , Debra Borchardt , Todd Davis , Travis Frey , Alex Gettlin , Jhavid Mohseni , Benzinga Cannabi , Julia Jacbonson , Oludare Odumosu , El Planteo , Massroots Inc , Holdings Inc , Cansortium Inc , Jazz Pharmaceuticals , Cronos Group Inc , Trademark Office , Medmen Enterprises Inc ,